These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16796993)

  • 1. Chaperone-like activities of alpha-synuclein: alpha-synuclein assists enzyme activities of esterases.
    Ahn M; Kim S; Kang M; Ryu Y; Kim TD
    Biochem Biophys Res Commun; 2006 Aug; 346(4):1142-9. PubMed ID: 16796993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro.
    Kim TD; Paik SR; Yang CH; Kim J
    Protein Sci; 2000 Dec; 9(12):2489-96. PubMed ID: 11206070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural evidence for alpha-synuclein fibrils using in situ atomic force microscopy.
    Zhang F; Ji LN; Tang L; Hu J; Hu HY; Xu HJ; He JH
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):113-8. PubMed ID: 15685368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
    Kong B; Chae Y; Lee K
    Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snaring the function of alpha-synuclein.
    Bonini NM; Giasson BI
    Cell; 2005 Nov; 123(3):359-61. PubMed ID: 16269324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein has structural and functional similarities to small heat shock proteins.
    Kim TD; Choi E; Rhim H; Paik SR; Yang CH
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1352-9. PubMed ID: 15504363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
    Halliday GM; McCann H
    Exp Neurol; 2008 Jan; 209(1):12-21. PubMed ID: 17706644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nitration on the structure and aggregation of alpha-synuclein.
    Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
    Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN
    J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein.
    Lee D; Paik SR; Choi KY
    FEBS Lett; 2004 Oct; 576(1-2):256-60. PubMed ID: 15474047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression.
    Fan Y; Limprasert P; Murray IV; Smith AC; Lee VM; Trojanowski JQ; Sopher BL; La Spada AR
    Hum Mol Genet; 2006 Oct; 15(20):3002-11. PubMed ID: 16959793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
    Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
    J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment.
    Kim HJ; Chatani E; Goto Y; Paik SR
    J Microbiol Biotechnol; 2007 Dec; 17(12):2027-32. PubMed ID: 18167451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
    Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
    J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.
    Bertoncini CW; Rasia RM; Lamberto GR; Binolfi A; Zweckstetter M; Griesinger C; Fernandez CO
    J Mol Biol; 2007 Sep; 372(3):708-22. PubMed ID: 17681539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.